Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nonmyeloablative haploidentical stem cell transplantation with pre- and post-transplant cyclophosphamide in high-risk hematologic malignancies
2009-018083-94Phase 2Completed
- Sponsor
- European Institute of Oncology
- Start
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of cyclophosphamide in hematopoietic malignancies, sponsored by European Institute of Oncology. Primary endpoint: Donor engraftment at day +84. Started Jul 2010; status: completed.
02
Drugs
cyclophosphamide
03
Conditions
hematopoietic malignancies
Beyond the preview
Go deeper on 2009-018083-94.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-018083-94.